Authors:
RIBEIRO CAF
ALMEIDA L
PAIVA I
TAVARES P
CABRITA S
WULFROTH P
BEJA MLM
TEIXEIRA F
Citation: Caf. Ribeiro et al., INFLUENCE OF 0.1-PERCENT OR 0.2-PERCENT CHOLESTEROL-ENRICHED DIETS ONTHE INDUCTION OF ATHEROSCLEROSIS AND AORTA REACTIVITY IN-VITRO, Journal of cardiovascular pharmacology, 31(5), 1998, pp. 690-699
Citation: Hp. Hammes et al., ANTIOXIDANT TREATMENT OF EXPERIMENTAL DIABETIC-RETINOPATHY IN RATS WITH NICANARTINE, Diabetologia, 40(6), 1997, pp. 629-634
Authors:
CARAMONA MM
COTRIM MD
FIGUEIREDO IV
TAVARES P
RIBEIRO CAF
BEJA ML
WULFROTH P
TEIXEIRA F
Citation: Mm. Caramona et al., INFLUENCE OF EXPERIMENTAL HYPERCHOLESTEROLEMIA ON THE MONOAMINE-OXIDASE ACTIVITY IN RABBIT ARTERIES, Pharmacological research, 33(4-5), 1996, pp. 245-249
Authors:
OKADA H
LUNDGREN C
BROWN SL
VINOGRADSKY B
WULFROTH P
FUJII S
Citation: H. Okada et al., EFFECT OF ETOFIBRATE AND NICANARTINE ON PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 PRODUCTION IN-VITRO BY CULTURED VASCULAR CELLS AND ON PLASMAPLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ACTIVITY IN-VIVO IN RABBITS, Current therapeutic research, 57(3), 1996, pp. 192-202
Authors:
SIEKMEIER R
WULFROTH P
WIELAND H
GROSS W
MARZ W
Citation: R. Siekmeier et al., LOW-DENSITY-LIPOPROTEIN SUSCEPTIBILITY TO IN-VITRO OXIDATION IN HEALTHY SMOKERS AND NONSMOKERS, Clinical chemistry, 42(4), 1996, pp. 524-530
Citation: H. Heinle et al., EFFECTS OF THE NEW ANTIOXIDANT NICANARTINE IN AN EXPERIMENTAL-MODEL OF ATHEROSCLEROSIS, Arzneimittel-Forschung, 46(10), 1996, pp. 956-959
Citation: R. Kinscherf et al., ETOFIBRATE SUPPRESSES NEOINTIMA FORMATION OF THE BALLOONED COMMON CAROTID-ARTERY OF RATS, Naunyn-Schmiedeberg's archives of pharmacology, 352(4), 1995, pp. 424-428
Authors:
TAVARES P
FONTES CA
BARBERO A
SILVA H
WULFROTH P
NOVOA JML
TEIXEIRA F
Citation: P. Tavares et al., CONTRIBUTION OF ENDOTHELIUM AND SMOOTH-MUSCLE CELLS TO VASCULAR CONTRACTION IN A CHOLESTEROL-ENRICHED ENVIRONMENT, British Journal of Pharmacology, 114, 1995, pp. 185-185
Authors:
WULFROTH P
RICHTER CM
BURKARD M
HUTH K
QUACK G
Citation: P. Wulfroth et al., ETOFIBRATE TREATMENT ALTERS LOW-DENSITY-LIPOPROTEIN SUSCEPTIBILITY TOLIPID-PEROXIDATION, Drugs under experimental and clinical research, 18(11-12), 1992, pp. 469-474